The beginning of 2020 was an exciting time for the Nu-Life team. After years of development, feasibility tests and production runs with more than 700 design changes and upgrades, Nu-V3 was ready for patient use in significant numbers. Enter Covid-19. Everything changed. Delivering Nu-V3 for use in a clinical environment was suddenly not possible and how or when we would be able to execute our clinical programs was an unknown.
A future version of Nu-V3 which allowed the device to be applied by the patient themselves was in the planning stage, but not yet finalized. A quick review of the global circumstances and the ability of our design team to act quickly, led to the now completed Nu-V3 2.0 which is simpler to apply for both patient and provider.
In tandem, with the help of our technology partners, we developed the Nu-V3 Remote Treatment Program designed to utilize Nu-V3 2.0 with the ability to manage the patient's treatment program virtually, through telemedicine.
We are excited to present Nu-V3 2.0 which has been designed to improve comfort, increase patient compliance, make Nu-V3 simple to use and the Nu-V3 program easy to follow.